Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Xigris in HSCT Patients with Severe Sepsis
NCT00067730Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of drotrecogin alfa in sepsis, sponsored by Eli Lilly and Company. Started Mar 2003; status: completed.
02
Drugs
drotrecogin alfa
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT00067730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067730.